TGFβ1 has also been found to be enriched in CML-Exo and treatment with TGF-β1 inhibitor significantly reduced Exo-stimulated cell proliferation and colony formation of CML cells [100]. This evidence concerns the gene TGFB1 and chronic myelogenous leukemia, BCR-ABL1 positive.